Hurt on a cruise? Free consultation · No recovery, no fee or costsENES1-866-597-4529
Class Actions

Zantac (Ranitidine) Lawsuit Update

Zantac (ranitidine) was pulled from the U.S. market in 2020 over concerns about NDMA, a probable human carcinogen. Here is where the Zantac lawsuits stand today, and what it means if you or a loved one took the drug.

SE HABLA ESPAÑOL · No Recovery. No Fee.

Why Aronfeld
  • $169M+recovered for our clients*
  • 35+years representing injured people
  • Board
    Certified
    in Civil Trial Law by The Florida Bar
  • $0No Recovery. No Fee.

*Past results do not guarantee a similar outcome.

As seen on
The New York TimesThe Wall Street JournalThe Washington PostCNNGood Morning AmericaNBC NewsABC NewsCBS NewsFox NewsBBCTelemundoUnivision

Why Zantac was taken off the market

In April 2020 the FDA asked manufacturers to withdraw all prescription and over-the-counter ranitidine products, including Zantac. Testing showed that NDMA, a contaminant the FDA considers a probable human carcinogen, could build up in ranitidine over time, especially when stored at higher temperatures.

Thousands of people who took Zantac for years and were later diagnosed with cancer filed lawsuits. The cases focused mainly on bladder, stomach, esophageal, pancreatic and liver cancer.

Where the Zantac lawsuits stand

  • Federal cases: the national multidistrict litigation in South Florida was dismissed in December 2022 after the judge excluded the plaintiffs’ scientific experts.
  • Settlements: in 2024 GSK agreed to resolve about 80,000 state-court cases for up to $2.2 billion. Other drugmakers settled large groups of cases as well.
  • Remaining state cases: in April 2026 a Delaware judge dismissed the remaining Delaware lawsuits, finding the evidence linking Zantac to cancer flawed.

The result: very few new Zantac claims can move forward today.

What this means for you

If you already have a Zantac case, ask your lawyer about its status and any settlement deadlines. If you never filed a claim, it is likely too late in most situations. Every case is different, though, and we will tell you honestly whether you have any options, at no cost.

Other dangerous drug and product cases

Aronfeld Trial Lawyers continues to represent people harmed by dangerous drugs, chemicals and medical devices. Learn more about Paraquat, Xeljanz, hip implant recalls and our other class action cases.

Call 866-597-4529 for a free, confidential consultation. No Recovery. No Fee. Se habla español.

Talk to a lawyer today

Free, confidential consultation. Available 24/7 in English and Spanish.

Call 866-597-4529Send us a message
FAQ

Frequently asked questions

Can I still file a Zantac lawsuit?

In most cases, probably not. The federal cases were dismissed, most state cases have settled or been dismissed, and filing deadlines have passed for many people. Call us and we will review your situation for free.

Why was Zantac recalled?

The FDA found that NDMA, a probable human carcinogen, could build up in ranitidine over time and with heat. In April 2020 it asked manufacturers to pull all ranitidine products from the market.

What cancers were linked to Zantac in the lawsuits?

The lawsuits focused mainly on bladder, stomach, esophageal, pancreatic and liver cancer.

Is Zantac still sold?

Ranitidine is no longer sold in the U.S. The product now sold as Zantac 360° contains a different drug, famotidine.

How much does it cost to talk to a lawyer?

Nothing. Consultations are free, and we work on a contingency fee: No Recovery. No Fee.

Free consultation

Injured? Talk to us today.

Tell us what happened. The consultation is free, and you pay nothing unless we recover for you — no attorney’s fees and no costs.

Sending this form doesn’t make you a client or create an attorney-client relationship. Please don’t include confidential details until we’ve spoken.